Jane M Anderson - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Jane M Anderson

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Handbook of Clinical Neurology|February 2, 2024

Status migrainosusSalwa Kamourieh, Todd Rozen, Jane M Anderson

Cutis|July 5, 2023

Artificial Intelligence vs Medical Providers in the Dermoscopic Diagnosis of MelanomaJane M Anderson, Izhaar Tejani, Tory Jarmain, et al.

Brain : a Journal of Neurology|July 28, 2010

Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunityJoanne L Jones, Jane M Anderson, Chia-Ling Phuah, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Handbook of Clinical Neurology|February 2, 2024

Status migrainosusSalwa Kamourieh, Todd Rozen, Jane M Anderson

Cutis|July 5, 2023

Artificial Intelligence vs Medical Providers in the Dermoscopic Diagnosis of MelanomaJane M Anderson, Izhaar Tejani, Tory Jarmain, et al.

Brain : a Journal of Neurology|July 28, 2010

Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunityJoanne L Jones, Jane M Anderson, Chia-Ling Phuah, et al.

Pageof 1